BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10884451)

  • 1. Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischemic stroke and thrombolytic therapy.
    Berrouschot J; Barthel H; Hesse S; Knapp WH; Schneider D; von Kummer R
    Stroke; 2000 Jul; 31(7):1545-51. PubMed ID: 10884451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of acute embolic stroke outcome after local intraarterial thrombolysis: value of pretreatment and posttreatment 99mTc-ethyl cysteinate dimer single photon emission computed tomography.
    Ogasawara K; Ogawa A; Doi M; Konno H; Suzuki M; Yoshimoto T
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1579-86. PubMed ID: 11083233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator.
    Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Scichinohe H; Nakayama N; Kazumata K; Houkin K
    J Stroke Cerebrovasc Dis; 2014; 23(5):896-901. PubMed ID: 24045082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based mapping of cortical ischemic damage using Tc 99m L,L-ethyl cysteinate dimer SPECT in acute stroke.
    Mahagne MH; David O; Darcourt J; Migneco O; Dunac A; Chatel M; Baron JC
    J Neuroimaging; 2004 Jan; 14(1):23-32. PubMed ID: 14748205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema.
    Berrouschot J; Barthel H; von Kummer R; Knapp WH; Hesse S; Schneider D
    Stroke; 1998 Dec; 29(12):2556-62. PubMed ID: 9836767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole.
    Song HC; Bom HS; Cho KH; Kim BC; Seo JJ; Kim CG; Yang DJ; Kim EE
    Stroke; 2003 Apr; 34(4):982-6. PubMed ID: 12649518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
    Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
    Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective value of perfusion and X-ray attenuation imaging with single-photon emission and transmission computed tomography in acute cerebral ischemia.
    Barthel H; Hesse S; Dannenberg C; Rössler A; Schneider D; Knapp WH; Dietrich J; Berrouschot J
    Stroke; 2001 Jul; 32(7):1588-97. PubMed ID: 11441206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.
    Chou C; Bourekas EC; Slivka A
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1823-1827. PubMed ID: 27133771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery.
    Mahagne MH; Darcourt J; Migneco O; Fournier JP; Thiercelin D; Ducoeur S; Bertrand F; Bussière F; Chatel M; Baron JC
    Cerebrovasc Dis; 2000; 10(5):364-73. PubMed ID: 10971022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
    Dzialowski I; Puetz V; Buchan AM; Demchuk AM; Hill MD;
    Stroke; 2012 Jun; 43(6):1567-71. PubMed ID: 22496336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.